semaglutide cvot Cardiovascular Outcomes Trial (CVOT) Long-term kidney outcomes of semaglutide

License this stock photo and more images of Stock photo Box containing a pre-filled pen of semaglutide diabetes medication

However, they also affect how the digestive system works

Glucagon-like peptide-1 agonist drugs have been surging in popularity, and manufacturers are scurrying to keep up with demand

For example, over-the-counter continuous glucose monitors (CGMs) are booming in popularity with curious consumers who want to monitor their blood sugar responses, wearables and smartphones are providing fine-grained remote monitoring (even giving digital nudges to support with sustained behavioural changes) and consumer apps for obesity and weight management are gaining significant use, with around 1.5 million installs on average1

Metabolism regulation